OBJECTIVE: Obese (OB) individuals and patients with Cushing's syndrome (CS) often have similar clinical presentations. While each group has reduced health-related quality of life (HRQL), it is not known whether the degree of impairment is different and might distinguish between them. The objective of this study was to compare HRQL in these two populations. DESIGN: Cross-sectional study. METHODS: Three hundred and twenty-seven OB patients (48.1±11.7 years; 72.5% women) with weight gain and at least two features of CS were recruited from an outpatient weight management clinic. Sixty-six untreated patients with CS (41.6±13.2 years; 78.8% women) presented to the NIH Clinical Center for evaluation. Subjects completed the SF-36 survey and a locally created symptom questionnaire. RESULTS: After adjusting for symptom count, OB patients had a significantly higher (better HRQL) mean physical component summary (PCS) score than CS patients (44.9±0.6 vs 35.4±1.5, P<0.0001). However, the mean mental component summary (MCS) score was lower (worse HRQL) in the OB group (41.6±0.6 vs 50.7±1.6, P<0.0001). Symptom count showed significant correlations with PCS and MCS scores. BMI correlated with PCS (r=-0.29) in OB but not in CS patients. BMI was not associated with MCS in either group. CONCLUSION: HRQL is significantly different between OB and CS patients. Surprisingly, after adjusting for symptom count, OB patients showed worse mental health scores than the CS population. Significant differences in HRQL and symptom count may suggest which OB patients should be screened for CS.
OBJECTIVE:Obese (OB) individuals and patients with Cushing's syndrome (CS) often have similar clinical presentations. While each group has reduced health-related quality of life (HRQL), it is not known whether the degree of impairment is different and might distinguish between them. The objective of this study was to compare HRQL in these two populations. DESIGN: Cross-sectional study. METHODS: Three hundred and twenty-seven OBpatients (48.1±11.7 years; 72.5% women) with weight gain and at least two features of CS were recruited from an outpatient weight management clinic. Sixty-six untreated patients with CS (41.6±13.2 years; 78.8% women) presented to the NIH Clinical Center for evaluation. Subjects completed the SF-36 survey and a locally created symptom questionnaire. RESULTS: After adjusting for symptom count, OBpatients had a significantly higher (better HRQL) mean physical component summary (PCS) score than CS patients (44.9±0.6 vs 35.4±1.5, P<0.0001). However, the mean mental component summary (MCS) score was lower (worse HRQL) in the OB group (41.6±0.6 vs 50.7±1.6, P<0.0001). Symptom count showed significant correlations with PCS and MCS scores. BMI correlated with PCS (r=-0.29) in OB but not in CS patients. BMI was not associated with MCS in either group. CONCLUSION: HRQL is significantly different between OB and CS patients. Surprisingly, after adjusting for symptom count, OBpatients showed worse mental health scores than the CS population. Significant differences in HRQL and symptom count may suggest which OBpatients should be screened for CS.
Authors: Ananthila Anandacoomarasamy; Ian D Caterson; Steven Leibman; Garett S Smith; Phillip N Sambrook; Marlene Fransen; Lyn M March Journal: Obesity (Silver Spring) Date: 2009-04-23 Impact factor: 5.002
Authors: David B Allison; Morgan Downey; Richard L Atkinson; Charles J Billington; George A Bray; Robert H Eckel; Eric A Finkelstein; Michael D Jensen; Angelo Tremblay Journal: Obesity (Silver Spring) Date: 2008-05-08 Impact factor: 5.002
Authors: S M Webb; X Badia; M J Barahona; A Colao; C J Strasburger; A Tabarin; M O van Aken; R Pivonello; G Stalla; S W J Lamberts; J E Glusman Journal: Eur J Endocrinol Date: 2008-05 Impact factor: 6.664
Authors: Elena Valassi; Alicia Santos; Maria Yaneva; Miklós Tóth; Christian J Strasburger; Philippe Chanson; John A H Wass; Olivier Chabre; Marija Pfeifer; Richard A Feelders; Stylianos Tsagarakis; Peter J Trainer; Holger Franz; Kathrin Zopf; Sabina Zacharieva; Steven W J Lamberts; Antoine Tabarin; Susan M Webb Journal: Eur J Endocrinol Date: 2011-06-29 Impact factor: 6.664
Authors: W Jack Rejeski; Wei Lang; Rebecca H Neiberg; Brent Van Dorsten; Gary D Foster; Matthew L Maciejewski; Richard Rubin; David F Williamson Journal: Obesity (Silver Spring) Date: 2006-05 Impact factor: 5.002
Authors: Edoardo Mannucci; Maria L Petroni; Nicola Villanova; Carlo M Rotella; Giovanni Apolone; Giulio Marchesini Journal: Health Qual Life Outcomes Date: 2010-08-23 Impact factor: 3.186
Authors: Cornelie D Andela; Margreet Scharloo; Alberto M Pereira; Ad A Kaptein; Nienke R Biermasz Journal: Pituitary Date: 2015-10 Impact factor: 4.107
Authors: M Vermalle; M Alessandrini; T Graillon; N C Paladino; K Baumstarck; F Sebag; H Dufour; T Brue; F Castinetti Journal: Endocrine Date: 2018-07-17 Impact factor: 3.633
Authors: Leah T Braun; Frederick Vogel; Stephanie Zopp; Thomas Marchant Seiter; German Rubinstein; Christina M Berr; Heike Künzel; Felix Beuschlein; Martin Reincke Journal: J Clin Endocrinol Metab Date: 2022-08-18 Impact factor: 6.134